{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:06:33Z","timestamp":1790960793953,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003355","name":"Garvan Institute of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003355","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022217","name":"Flinders Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023560","name":"Bioplatforms Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013060","name":"European Molecular Biology Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000947","name":"Australian Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.xcrm.2023.100971","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T01:16:16Z","timestamp":1676596576000},"page":"100971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines"],"prefix":"10.1016","volume":"4","author":[{"given":"Feargal J.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd S.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"McCafferty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie E.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina L.","family":"Eden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee C.","family":"Tee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saoirse C.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makutiro G.","family":"Masavuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur E.L.","family":"Yeow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunasingam","family":"Abayasingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Agapiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Zecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Ignjatovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Monagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyen","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"McFadyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowena A.","family":"Bull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka","family":"Grubor-Bauk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam A.","family":"Lynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle","family":"Botten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone E.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4664-1404","authenticated-orcid":false,"given":"David J.","family":"Lynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.100971_bib1","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","article-title":"Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine","volume":"385","author":"Falsey","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib2","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib4","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/s41590-022-01212-3","article-title":"Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose","volume":"23","author":"Lustig","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2023.100971_bib5","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib6","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41591-022-01753-y","article-title":"Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and delta variants","volume":"28","author":"Tseng","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib7","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJMc2201821","article-title":"Protection with a third dose of mRNA vaccine against SARS-CoV-2 variants in frontline workers","volume":"386","author":"Yoon","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib8","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib9","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6\u00a0months","volume":"385","author":"Levin","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib10","doi-asserted-by":"crossref","first-page":"eabo2202","DOI":"10.1126\/sciimmunol.abo2202","article-title":"Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients","volume":"7","author":"GeurtsvanKessel","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2023.100971_bib11","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.100971_bib12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","article-title":"Systems vaccinology of the BNT162b2 mRNA vaccine in humans","volume":"596","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.100971_bib13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1126\/science.aax8819","article-title":"MAIT cell activation augments adenovirus vector vaccine immunogenicity","volume":"371","author":"Provine","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.100971_bib14","doi-asserted-by":"crossref","first-page":"100631","DOI":"10.1016\/j.xcrm.2022.100631","article-title":"Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine","volume":"3","author":"Takano","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41591-021-01630-0","article-title":"Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection","volume":"28","author":"Patone","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib16","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2109730","article-title":"Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel","volume":"385","author":"Mevorach","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib17","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting","volume":"385","author":"Barda","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib18","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib19","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib20","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib21","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41591-021-01408-4","article-title":"First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland","volume":"27","author":"Simpson","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-021-03739-1","article-title":"Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2","volume":"596","author":"Collier","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.100971_bib23","doi-asserted-by":"crossref","first-page":"eabn3127","DOI":"10.1126\/sciimmunol.abn3127","article-title":"SARS-CoV-2-specific T\u00a0cells in unexposed adults display broad trafficking potential and cross-react with commensal antigens","volume":"7","author":"Bartolo","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2023.100971_bib24","doi-asserted-by":"crossref","first-page":"eabj9853","DOI":"10.1126\/science.abj9853","article-title":"Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T\u00a0cells","volume":"374","author":"Mateus","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.100971_bib25","doi-asserted-by":"crossref","first-page":"eabh1823","DOI":"10.1126\/science.abh1823","article-title":"Cross-reactive CD4(+) T\u00a0cells enhance SARS-CoV-2 immune responses upon infection and vaccination","volume":"374","author":"Loyal","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.100971_bib26","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3389\/fimmu.2019.02458","article-title":"Challenges and opportunities for consistent classification of human B cell and plasma cell populations","volume":"10","author":"Sanz","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2023.100971_bib27","doi-asserted-by":"crossref","first-page":"eaag2152","DOI":"10.1126\/sciimmunol.aag2152","article-title":"Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells","volume":"2","author":"Herati","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2023.100971_bib28","doi-asserted-by":"crossref","first-page":"176ra32","DOI":"10.1126\/scitranslmed.3005191","article-title":"Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination","volume":"5","author":"Bentebibel","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib29","doi-asserted-by":"crossref","first-page":"eabl8213","DOI":"10.1126\/sciadv.abl8213","article-title":"ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome","volume":"7","author":"Baker","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2023.100971_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cellimm.2016.08.002","article-title":"Phosphatidylcholine as a metabolic cue for determining B cell fate and function","volume":"310","author":"Brewer","year":"2016","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.xcrm.2023.100971_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biology study of five human vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2023.100971_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.100971_bib33","doi-asserted-by":"crossref","first-page":"109504","DOI":"10.1016\/j.celrep.2021.109504","article-title":"Systemic IL-15, IFN-gamma, and IP-10\/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients","volume":"36","author":"Bergamaschi","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2023.100971_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2014.03.031","article-title":"Global analyses of human immune variation reveal baseline predictors of postvaccination responses","volume":"157","author":"Tsang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.100971_bib35","series-title":"COVID-19 vaccine adverse events","author":"Therapeutic Goods Administration","year":"2022"},{"key":"10.1016\/j.xcrm.2023.100971_bib36","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.xcrm.2023.100971_bib37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2023.100971_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2023.100971_bib39","doi-asserted-by":"crossref","first-page":"eaan8405","DOI":"10.1126\/scitranslmed.aan8405","article-title":"Circulating TFH cells, serological memory, and tissue compartmentalization shape\u00a0human influenza-specific B cell immunity","volume":"10","author":"Koutsakos","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib40","doi-asserted-by":"crossref","first-page":"e40385","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2023.100971_bib41","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2023.100971_bib42","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.immuni.2022.08.003","article-title":"The pre-exposure SARS-CoV-2-specific T\u00a0cell repertoire determines the quality of the immune response to vaccination","volume":"55","author":"Saggau","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2023.100971_bib43","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3324\/haematol.2021.280154","article-title":"Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines","volume":"107","author":"Michalik","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.xcrm.2023.100971_bib44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2023.100971_bib45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.imlet.2014.11.001","article-title":"B cell epitope spreading: mechanisms and contribution to autoimmune diseases","volume":"163","author":"Cornaby","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.xcrm.2023.100971_bib46","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.immuni.2022.01.013","article-title":"Bacterial infection disrupts established germinal center reactions through monocyte recruitment and impaired metabolic adaptation","volume":"55","author":"Biram","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2023.100971_bib47","doi-asserted-by":"crossref","first-page":"eaah6789","DOI":"10.1126\/sciimmunol.aah6789","article-title":"Inflammatory monocytes hinder antiviral B cell responses","volume":"1","author":"Sammicheli","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2023.100971_bib48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.medj.2021.12.004","article-title":"Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients","volume":"3","author":"Khoo","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.xcrm.2023.100971_bib49","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T\u00a0cell memory able to cross-recognize variants from Alpha to Omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.100971_bib50","doi-asserted-by":"crossref","first-page":"104073","DOI":"10.1016\/j.ebiom.2022.104073","article-title":"Heterologous ChAdOx1\/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: the pragmatic, multi-center, three-arm, partially randomized HEVACC trial","volume":"80","author":"B\u00e1nki","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2023.100971_bib51","doi-asserted-by":"crossref","first-page":"eaal2192","DOI":"10.1126\/sciimmunol.aal2192","article-title":"Single-cell RNA-seq and computational analysis using temporal mixture modelling resolves Th1\/Tfh fate bifurcation in malaria","volume":"2","author":"L\u00f6nnberg","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2023.100971_bib52","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.immuni.2011.11.012","article-title":"Early Th1 cell differentiation is marked by a Tfh cell-like transition","volume":"35","author":"Nakayamada","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2023.100971_bib53","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.cell.2022.01.018","article-title":"Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination","volume":"185","author":"R\u00f6ltgen","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.100971_bib54","doi-asserted-by":"crossref","first-page":"779212","DOI":"10.3389\/fimmu.2021.779212","article-title":"Anti-SARS-CoV-2 spike protein RBD antibody levels after receiving a second dose of ChAdOx1 nCov-19 (AZD1222) vaccine in healthcare workers: lack of association with age, sex, obesity, and adverse reactions","volume":"12","author":"Lee","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2023.100971_bib55","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques","volume":"590","author":"McMahan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.100971_bib56","doi-asserted-by":"crossref","first-page":"eabq7647","DOI":"10.1126\/sciimmunol.abq7647","article-title":"CD8 T\u00a0cells contribute to vaccine protection against SARS-CoV-2 in macaques","volume":"7","author":"Liu","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2023.100971_bib57","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/s41590-022-01328-6","article-title":"Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses","volume":"23","author":"Hagan","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2023.100971_bib58","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/s41590-022-01329-5","article-title":"Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination","volume":"23","author":"Fourati","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2023.100971_bib59","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.100971_bib60","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib61","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1128\/JVI.00248-09","article-title":"Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity","volume":"83","author":"Keck","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2023.100971_bib62","doi-asserted-by":"crossref","first-page":"14199","DOI":"10.1073\/pnas.2335981100","article-title":"In\u00a0vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes","volume":"100","author":"Bartosch","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.100971_bib63","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells","volume":"78","author":"Hoffmann","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2023.100971_bib64","article-title":"Optimised cell systems for the investigation of hepatitis C virus E1E2 glycoproteins","author":"Kalemera","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2023.100971_bib65","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/v12050513","article-title":"Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays","volume":"12","author":"Crawford","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2023.100971_bib66","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.100971_bib67","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.100971_bib68","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2023.100971_bib69","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.100971_bib70","doi-asserted-by":"crossref","first-page":"D884","DOI":"10.1093\/nar\/gkaa942","article-title":"Ensembl 2021","volume":"49","author":"Howe","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.100971_bib71","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.100971_bib72","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1093\/nar\/gku864","article-title":"svaseq: removing batch effects and other unwanted noise from sequencing data","volume":"42","author":"Leek","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.100971_bib73","series-title":"Package \u2018hmisc\u2019. CRAN2018 2019","first-page":"235","author":"Harrell","year":"2019"},{"key":"10.1016\/j.xcrm.2023.100971_bib74","series-title":"Package \u2018ggplot2\u2019: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.xcrm.2023.100971_bib75","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.100971_bib76","series-title":"msigdbr: MSigDB Gene Sets for Multiple Organisms in a Tidy Data Format. R Package Version 7","author":"Dolgalev","year":"2020"},{"key":"10.1016\/j.xcrm.2023.100971_bib77","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/cyto.a.24350","article-title":"Integration, exploration, and analysis of high-dimensional single-cell cytometry data using Spectre","volume":"101","author":"Ashhurst","year":"2022","journal-title":"Cytometry A."},{"key":"10.1016\/j.xcrm.2023.100971_bib78","doi-asserted-by":"crossref","first-page":"100228","DOI":"10.1016\/j.xcrm.2021.100228","article-title":"Long-term persistence of RBD(+) memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection","volume":"2","author":"Abayasingam","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2023.100971_bib79","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.100971_bib80","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/acs.jproteome.9b00217","article-title":"Universal solid-phase protein preparation (USP3) for bottom-up and top-down proteomics","volume":"18","author":"Dagley","year":"2019","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.xcrm.2023.100971_bib81","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/nprot.2007.261","article-title":"Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips","volume":"2","author":"Rappsilber","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2023.100971_bib82","article-title":"High sensitivity dia-PASEF proteomics with DIA-NN and\u00a0FragPipe","author":"Demichev","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2023.100971_bib83","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.chembiol.2018.10.008","article-title":"High-throughput plasma lipidomics: detailed mapping of the associations with cardiometabolic risk factors","volume":"26","author":"Huynh","year":"2019","journal-title":"Cell Chem. Biol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123000769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123000769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:53:35Z","timestamp":1762988015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379123000769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2666379123000769"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.100971","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.100971","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100971"}}